RevistaLab
Revista recently released data for the 1st quarter of 2025. The preliminary transaction data shows 14 life science properties traded hands during the quarter. As per the chart, 70 properties traded over . . .
The Life Science Real Estate (LSRE) sector, like many other commercial real estate sectors, has seen transaction activity slow in recent years. Higher interest rates have created an uneasy investing and lending environment. The LSRE sector . . .
Preliminary data shows a total of $3.16 billion for life science sales in 2024, totaling 5.17 million square feet. This is equivalent to about half of the volume recorded in 2023. Yearly volume has maintained a consistent decline since 2022, and 2024 has yet to show a clear reversal. On a positive note, if . . .
The first half of 2024 was slow going for life science property sales. About 1.5 million square feet traded hands, and the previous trend of declining activity continued. With rate cuts from this from this past September, are there any signs of a pivot? The chart below includes our preliminary data for 3Q and the
For those tracking the Life Science Real Estate Sector (LSRE) it should be no surprise that supply is growing currently.
It will come as no surprise to report that transaction activity was rather slow in 2Q24. Volume has been on a downward trend since the end of 2022, and the recent quarter is no exception. While the market sentiment has been consistent over the past year, it is crucial to keep tabs, especially as we approach a potential pivot point. Just under
The 2Q24 construction numbers show a continuation of the decline in new projects. The chart below shows the square footage of projects starting and completing construction on an annual basis. 12.2 million square feet have started construction in the past year, and 20.3 million have been completed. Beginning . . .
Revista recently hosted a webcast discussing the latest data and insights for the Life Science Real Estate industry as of 1Q24. Hilda Martin and Stephen Lindsey reviewed details on supply/demand, …
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
Life Science real estate transaction volume picked up at the end of 2023, according to newly released data from www.revistalab.com.
The cap rates for life science real estate deals have been increasing after reaching a low point in the fourth quarter of 2021. The compression down to 4.2 coincided with a peak in transaction volume of almost 20 billion dollars on an annual basis.
Did you know Revistalab tracks life science real estate (LSRE) construction across the country? RevistaLab covers lab construction projects, including conversions expansions and new properties across the US that are in planning, in progress as well as completed.
Did you know that www.revistalab.com is tracking real estate transaction activity within the Life Science Real Estate Sector? We have trend data on transaction volumes, prices per square foot, and even cap rates starting in 2020 to present.
Over the past few years, a spotlight has been on the Life Science industry (and the real estate that serves it) due to the pandemic and the rush to create …
Unprecedented levels of funding into biotech and pharmaceutical companies in recent years has created explosive growth in the sector. That growth eventually translates into the need for more space. Are …